There is no defined standard chemotherapy and there is currently no robust, prospective, randomized data to advise different use of specific chemotherapy agents in TNBC as compared to non-TNBC. Data suggest high sensitivity to chemotherapy, however it is yet to be determined whether this increased sensitivity is agent/regimen specific or whether it reflects general chemosensitivity.
Adjuvant systemic treatment for individual patients with triple negative breast cancer / Oakman C; Moretti E; Galardi F; Biagioni C; Santarpia L; Biganzoli L; Di Leo A. - In: THE BREAST. - ISSN 0960-9776. - ELETTRONICO. - (2011), pp. S135-S141.
Adjuvant systemic treatment for individual patients with triple negative breast cancer
MORETTI, ERICA;
2011
Abstract
There is no defined standard chemotherapy and there is currently no robust, prospective, randomized data to advise different use of specific chemotherapy agents in TNBC as compared to non-TNBC. Data suggest high sensitivity to chemotherapy, however it is yet to be determined whether this increased sensitivity is agent/regimen specific or whether it reflects general chemosensitivity.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
